Old Web
English
Sign In
Acemap
>
Paper
>
Deregulation of A-to-I RNA editing is associated with poor prognosis in HER2+ breast cancers in the neoALTTO trial
Deregulation of A-to-I RNA editing is associated with poor prognosis in HER2+ breast cancers in the neoALTTO trial
2017
David Venet
Françoise Rothé
Floriane Dupont
Marion Maetens
Debora Fumagalli
Roberto Salgado
Ian Bradbury
Lajos Pusztai
Nadia Harbeck
Miguel A. Izquierdo
Lorena de la Peña
Michail Ignatiadis
Evandro de Azambuja
Jens Huober
P Nuciforo
José Baselga
Martine Piccart-Gebhart
Sherene Loi
Christos Sotiriou
Keywords:
Deregulation
Cancer research
RNA editing
Biology
Oncology
Internal medicine
poor prognosis
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]